{"8JF05foAAAAJ": [["Alexander Nevelsky", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Robert S Kerbel", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Dvir Shechter", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Tongwu Zhang", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Elisabeth GE de Vries", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Ksenia Magidey", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Tal Kan", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Ruslana Kotsofruk", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Michael Timaner", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Shahar Daniel", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Orit Kaidar-Person", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Ziv Raviv", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Yuval Shaked", 2020, "Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1"], ["Shan Man", 2019, "Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer"], ["Ping Xu", 2019, "Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer"], ["Elaine Reguera-Nu\u00f1ez", 2019, "Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer"], ["Annabelle Chow", 2019, "Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer"], ["Frank Hilberg", 2019, "Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer"], ["Luc Y Dirix", 2019, "RE: The tumor as organizer model"], ["Francesco Pezzella", 2019, "RE: The tumor as organizer model"], ["Peter B Vermeulen", 2019, "RE: The tumor as organizer model"], ["Elizabeth A Kuczynski", 2019, "RE: The tumor as organizer model"], ["Andrew R Reynolds", 2019, "RE: The tumor as organizer model"], ["Kate Connor", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Patrick Dicker", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Liam P Shiels", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Ian S Miller", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Annette T Byrne", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["William M Gallagher", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Emer Conroy", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Norma O\u2019Donovan", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["John Crown", 2019, "Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents"], ["Robert Kerbel", 2019, "Blood vessels and cancer"], ["Cameron Phillips", 2019, "Personalized use of metronomic cyclophosphamide for DNA repair deficient castration-resistant prostate cancer: A phase II trial."], ["Giulio Francia", 2019, "Personalized use of metronomic cyclophosphamide for DNA repair deficient castration-resistant prostate cancer: A phase II trial."], ["Urban Emmenegger", 2019, "Personalized use of metronomic cyclophosphamide for DNA repair deficient castration-resistant prostate cancer: A phase II trial."], ["Geoffrey A Wood", 2019, "Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion"], ["William Cruz-Munoz", 2019, "Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion"], ["Alicia Viloria-Petit", 2019, "Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion"], ["Raquel Mu\u00f1oz", 2019, "Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion"], ["Denise Hileeto", 2019, "Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion"], ["Kabir A Khan", 2019, "Pre-and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro-or macro-metastatic disease"], ["Elizabeth Pham", 2019, "Pre-and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro-or macro-metastatic disease"], ["Marta Paez-Ribes", 2019, "Pre-and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro-or macro-metastatic disease"], ["Florence TH Wu", 2019, "Pre-and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro-or macro-metastatic disease"], ["Janna Kr\u00fcger", 2019, "Pre-and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro-or macro-metastatic disease"], ["Bahar Yetkin-Arik", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Robert Auerbach", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Juan M Melero-Martin", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Joanna Kalucka", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Daniel Castranova", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Domenico Ribatti", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Kristian Pietras", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Jan Kitajewski", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Roberto F Nicosia", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Bart Ghesqui\u00e8re", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Gabriel A Rabinovich", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Stefan Schulte-Merker", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Anna Dimberg", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Ondine Cleaver", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Patrycja Nowak-Sliwinska", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Marius Raica", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["George E Davis", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Agnes Noel", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Mark J Post", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Tatiana V Petrova", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Lois EH Smith", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Maureen Van de Velde", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Napoleone Ferrara", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Ingeborg Klaassen", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Roberto Pili", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Arjan W Griffioen", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Jeffrey W Pollard", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Koen Marien", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Michele De Palma", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Seppo Yla-Herttuala", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Elizabeth Allen", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Johannes Waltenberger", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Peter C Brooks", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Mervin C Yoder", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Elisabeth Kuczynski", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["R Hugh F Bender", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Yan Gong", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Hynda K Kleinmann", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Sarah-Maria Fendt", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Hong Xin", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Marcus Fruttiger", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Raghu Kalluri", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Andrey Anisimov", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Gabriele Bergers", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Adrian L Harris", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Anna M Randi", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Jussi Nurro", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Neil P Dufton", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Paul HA Quax", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Bertan Cakir", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Federico Bussolino", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Valentin Djonov", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Anca M Cimpean", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Rakesh K Jain", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Reinier O Schlingemann", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Pieter Koolwijk", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Peter Carmeliet", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Melita Irving", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Jonathan W Song", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Dai Fukumura", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Andreas Bikfalvi", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Nan W Hultgren", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Brant M Weinstein", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Judy R van Beijnum", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["David O Bates", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Curzio Ruegg", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Andrew C Dudley", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Robert J Griffin", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Amber N Stratman", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Jimmy Stalin", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Kari Alitalo", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Ruud PM Dings", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["George Coukos", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["M Luisa Iruela-Arispe", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Barbara C B\u00f6ck", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Brenda R Kwak", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Joyce Bischoff", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Victor WM van Hinsbergh", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Alfred C Aplin", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Lance L Munn", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Steven A Stacker", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Anna-Karin Olsson", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Christopher CW Hughes", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Hellmut G Augustin", 2018, "Consensus guidelines for the use and interpretation of angiogenesis assays"], ["Joel Martinez", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Guido Bocci", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Jose Lopez", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Valeria Rolih", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Diana Gonzalez Garcia", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Paloma Valenzuela", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Karla Parra", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Valerie Gallegos", 2018, "Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts"], ["Melissa Dolan", 2018, "Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors"], ["Christina R Lee", 2018, "Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors"], ["John ML Ebos", 2018, "Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors"], ["Amanda Tracz", 2018, "Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors"], ["Michalis Mastri", 2018, "Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors"], ["Yuhao Shi", 2018, "Tumor-independent host secretomes induced by angiogenesis and immune-checkpoint inhibitors"], ["Meaghan A O\u2019Reilly", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Kathleen I Pritchard", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Sheng-Kai Wu", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Gregory J Czarnota", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Arjun Sahgal", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Kullervo Hynynen", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Tricia Chinnery", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["My-Linh Yee", 2018, "Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases"], ["Kevin Gatter", 2018, "Non-angiogenic tumours and their influence on cancer biology"], ["Tom Donnem", 2018, "Non-angiogenic tumours and their influence on cancer biology"], ["Paul M Krzyzanowski", 2018, "Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors"], ["Yogi Sundaravadanam", 2018, "Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors"], ["Janna Krueger", 2018, "Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors"], ["Jessica K Miller", 2018, "Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors"], ["Raquel De Souza", 2018, "Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice"], ["Inga B Fricke", 2018, "Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice"], ["Jinzi Zheng", 2018, "Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice"], ["David A Jaffray", 2018, "Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice"], ["Lais Costa Ayub", 2018, "Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice"]]}